Macquarie has released a research report noting that CONANT OPTICAL recently signed a memorandum of understanding with a globally leading smart glasses technology company to manufacture its next-generation smart glasses. The firm views this as a significant milestone for CONANT, given its leadership in ultra-thin lens technology for display-enabled eyewear and its possession of global certifications (FDA, CE, ISO). The company is one of the few prescription lens manufacturers worldwide capable of collaborating with major tech firms on the development of next-generation smart glasses. Macquarie has reduced its earnings per share forecasts for CONANT OPTICAL for 2026 and 2027 by 20% and 8%, respectively, reflecting lowered revenue projections for its AI glasses business and an adjustment in the number of shares. However, the firm maintains its "Outperform" rating. The target price has been revised downward from HK$95.6 to HK$88, based on an unchanged forecasted 2027 price-to-earnings ratio of 30 times.
Comments